ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Majority of patients with depression getting poor care
March 31, 2017Seventy-five percent of people with major depression in Europe are not receiving adequate treatment, and yet it is the ... -
Diurnal and Clinigen to introduce patient access programme for unlicensed products in Europe
March 20, 2017UK-based pharmaceutical company Diurnal has collaborated with Clinigen's IDIS managed access unit to introduce a... -
Toxicological risk evaluation of extractable and leachable from single use systems used to manufactu
March 14, 2017Regulatory guidance states and industry best practices encourage drug safety specification, data to address potential issues not addressed during clinical studies. -
First patient enrolled in Phase II study evaluating JZP-110 for excessive sleepiness in Parkinson's
February 14, 2017JZP-110 is a selective dopamine and norepinephrine reuptake inhibitor. -
RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroe
February 14, 2017RedHill Biopharma Ltd. announced enrollment of the last patient in the Phase III study with BEKINDA® 24 mg for the treatment of acute gastroenteritis and gastritis (the GUARD study).
Pharma Sources Insight January 2025
